919 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Twin-Tracks Advair Competitor's Launch https://seekingalpha.com/article/4064230-teva-twin-tracks-advair-competitors-launch?source=feed_tag_israel Apr 21, 2017 - Having secured approval for the first lookalike competitor to Glaxosmithkline's (NYSE:GSK) Advair, Teva's (NYSE:TEVA) strategy is to launch it in the way it knows best: as a generic. In announcing US
Better Big Pharma Dividend Stock: Pfizer Or Teva? https://seekingalpha.com/article/4063968-better-big-pharma-dividend-stock-pfizer-teva?source=feed_sector_healthcare Apr 21, 2017 - Written by Bob Ciura for Sure Dividend on April 19th, 2017. Investors can count on the health care sector for dividends. Pfizer (NYSE:PFE) and Teva Pharmaceuticals (NYSE:TEVA) have dividend yields of
Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharmaceutical ... http://www.gurufocus.com/news/507612/penn-davis-mcfarland-inc-buys-celgene-bristolmyers-squibb-company-sells-teva-pharmaceutical-industries-skechers-usa-chevron Apr 20, 2017 - Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharmaceutical Industries, Skechers USA, Chevron, Stocks: CELG,BMY,TEVA,SKX,CVX,FIT,HCP,, release date:Apr 20, 2017
Teva launches new asthma meds https://seekingalpha.com/news/3258355-teva-launches-new-asthma-meds?source=feed_news_all Apr 20, 2017 - Teva Pharmaceutical Industries (TEVA +0.3%) announces the simultaneous U.S. launch of AirDuo RespiClick (fluticasone propionate and salmeterol) and its authorized generic for the treatment of asthma p
Did Pharma & Biotech M&As Pick Pace in Q1? http://www.zacks.com/stock/news/256645/did-pharma-biotech-mas-pick-pace-in-q1?cid=CS-ZC-FT-256645 Apr 18, 2017 - Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.
Neurocrine's Stock Up, FDA Nod for Tardive Dyskinesia Drug http://www.zacks.com/stock/news/256416/neurocrines-stock-up-fda-nod-for-tardive-dyskinesia-drug?cid=CS-ZC-FT-256416 Apr 13, 2017 - Shares of Neurocrine Biosciences, Inc. (NBIX) soared 25% on Tuesday after announcing the FDA approval ofIngrezza (valbenazine) capsules a day before for the treatment of adults with tardive dyskinesia (TD).
Teva slapped with FDA Warning Letter related to China site https://seekingalpha.com/news/3257099-teva-slapped-fda-warning-letter-related-china-site?source=feed_news_all Apr 13, 2017 - Teva Pharmaceutical industries (TEVA -0.4%) reports that it received a Warning Letter from the FDA on April 10 related to violations observed during an on-site inspection at its plant in China, specif
Teva Delivers Some Good News As Pressure Builds https://seekingalpha.com/article/4060156-teva-delivers-good-news-pressure-builds?source=feed_tag_israel Apr 04, 2017 - Teva (NYSE:TEVA) managed to deliver investors some badly needed good news last night, in the shape of US approval for its Huntington’s treatment Austedo. After last year’s complete response letter the
Allergan Acne Candidate Meets Endpoints in Phase III Studies http://www.zacks.com/stock/news/254397/allergan-acne-candidate-meets-endpoints-in-phase-iii-studies?cid=CS-ZC-FT-254397 Mar 28, 2017 - Allergan plc (AGN) in collaboration with Paratek Pharmaceuticals, Inc. (PRTK) has announced positive results from two phase III studies on sarecycline
Risk-Reward With Teva Pharmaceutical http://www.gurufocus.com/news/495637/riskreward-with-teva-pharmaceutical Mar 27, 2017 - Risk-Reward With Teva Pharmaceutical, Stocks: AGN,TEVA, David Tepper, release date:Mar 27, 2017
<<<Page 86>